Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study.
about
Letter: efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study (diabetes metab j 2013;37:117-24).Response: efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study (diabetes metab j 2013;37:117-24).The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical study.Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial.15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes.
P2860
Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Efficacy and safety of biphasi ...... open-label, single-arm study.
@en
type
label
Efficacy and safety of biphasi ...... open-label, single-arm study.
@en
prefLabel
Efficacy and safety of biphasi ...... open-label, single-arm study.
@en
P2093
P2860
P1476
Efficacy and safety of biphasi ...... open-label, single-arm study.
@en
P2093
Hyun-Shik Son
Jung Min Kim
Jung-Hyun Noh
Kee-Ho Song
Kyong Wan Min
Kyung Soo Ko
Yongsoo Park
P2860
P304
P356
10.4093/DMJ.2013.37.2.117
P577
2013-04-16T00:00:00Z